Gallentes, Adrian Jade A.
HRN: 23-76-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/18/2023
10/25/2023
IV
52mg
Q24h
Omphalitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes